HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Clinical trials for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Video Check-Ins could boost heart failure Self-Care
Disease control CompletedThis study tests whether regular video calls with a nurse can help people with heart failure manage their condition better than audio-only calls. About 140 adults with heart failure will be randomly assigned to receive either video or audio calls at 7, 30, 60, 180, and 365 days a…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: NA • Sponsor: Federal University of Uberlandia • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
Heart failure drug vericiguat put to the test in small trial
Disease control CompletedThis completed phase 4 trial tested whether vericiguat, a drug already approved for heart failure, can improve blood vessel function, reduce inflammation, and enhance quality of life in 26 people with heart failure with reduced ejection fraction. Participants received either veri…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE4 • Sponsor: Josef Stehlik • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New heart failure drug shows early promise in safety trial
Symptom relief CompletedThis early-stage study tested a new drug called XXB750 in 27 adults with stable heart failure and reduced heart pumping ability. The main goal was to see if the drug is safe and tolerable. Participants received either the drug or a placebo, and researchers monitored for side effe…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Metabolic clues may predict deadly heart rhythms in heart failure
Knowledge-focused CompletedThis completed study looked at 60 heart failure patients with reduced pumping function and dangerous heart rhythms. Researchers compared metabolic profiles between those with ischemic (blocked arteries) and non-ischemic (other causes) heart disease. By analyzing blood samples, th…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Sponsor: Muhammed Heja Geçit • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New model aims to predict heart failure death risk more accurately
Knowledge-focused CompletedThis study looked at medical records of 4,000 heart failure patients to see if combining routine blood tests (like NT-proBNP) with heart scan results (like fat density around the heart) can better predict who is at risk of dying within a year. The goal is to improve personalized …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Sponsor: Xinjiang Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC